Intranasal Sufentanil: Clinical Trials

2 trials of Intranasal Sufentanil, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow Intranasal Sufentanil: new trials by email Literature Review of Intranasal Sufentanil trials Research Report on Intranasal Sufentanil

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sufentanil Versus Ketamine Intranasally in the Management of Severe Acute Trauma-related Pain in Children.
Intranasal Sufentanil, Intranasal Ketamine (IN) - Traumatology, Wounds and Injury
Phase 2Not yet recruitingFondation Lenval1162026-02-052026-01-28
A Non-randomised, Non-inferiority Comparative Study of Oral Actiskenan (Morphine Sulfate) Versus Intranasal Sufentanil in the Early Management of Severe Acute Pain in Emergency Departments.
Intranasal Sufentanil, Oral Actiskenan - Severe Acute Pain
WithdrawnGroupe Hospitalier de la Region de Mulhouse et Sud Alsace2026-01-312026-05-08

Conditions studied

Acute Pain (2)  ·  Agnosia (2)  ·  Emergencies (1)  ·  Fractures, Bone (1)  ·  Pain (1)  ·  Wounds and Injuries (1)

Sponsors

Fondation Lenval (1)  ·  Groupe Hospitalier de la Region de Mulhouse et Sud Alsace (1)

Countries

France (2)

Results publications

PMID 42161544

NIH funding

2025 (1)